Tech Company Financing Transactions
Epocrates Funding Round
Epocrates closed a funding round on 1/7/2008. Investors included Goldman Sachs.
Transaction Overview
Company Name
Announced On
1/7/2008
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Goldman Sachs (Michael Sanders)
Proceeds Purpose
As part of the agreement, Hudson Street, a Goldman Sachs business, will co-market Epocrates' market research products and services to its institutional clients in the financial sector.
Company Information
Company Status
Acquired or Merged
Industry
Enterprise IT
Mailing Address
1100 Park Place 300
San Mateo, CA 94403
USA
San Mateo, CA 94403
USA
Phone
Website
Email Address
Overview
Epocrates, Inc. is transforming the practice of medicine by developing innovative solutions that support clinical decisions at the point of care. More than 500,000 healthcare professionals, including more than one in four U.S. physicians, actively use Epocrates' mobile and web-based products to improve patient safety and save time.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Brandt
Chief Financial Officer
Patrick Spangler
Chief Medical Officer
Thomas Giannulli
Chief Operating Officer
David Burlington
VP - General Counsel
Matthew Kaminer
VP - Human Resources
Kathleen Donovan
Browse more venture capital transactions:
Prev: 1/7/2008: Aragon Surgical venture capital transaction
Next: 1/7/2008: Validity Sensors venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs